Dr. Bai’s research interests lie in development and refinement of bioinformatics algorithms/software and databases on next-generation sequencing (NGS data), development of statistical model for solving biological problems, bioinformatics analysis of clinical data, as well as other topics including, but not limited to, uncovering disease genes and variants using informatics approaches, computational analysis of cis-regulation and comparative motif finding, large-scale genome annotation, comparative “omics”, and evolutionary genomics.
Hyun Min Kang is an Associate Professor in the Department of Biostatistics. He received his Ph.D. in Computer Science from University of California, San Diego in 2009 and joined the University of Michigan faculty in the same year. Prior to his doctoral studies, he worked as a research fellow at the Genome Research Center for Diabetes and Endocrine Disease in the Seoul National University Hospital for a year and a half, after completing his Bachelors and Masters degree in Electrical Engineering at Seoul National University. His research interest lies in big data genome science. Methodologically, his primary focus is on developing statistical methods and computational tools for large-scale genetic studies. Scientifically, his research aims to understand the etiology of complex disease traits, including type 2 diabetes, bipolar disorder, cardiovascular diseases, and glomerular diseases.
Dr. Veera Baladandayuthapani is currently a Professor in the Department of Biostatistics at University of Michigan (UM), where he is also the Associate Director of the Center for Cancer Biostatistics. He joined UM in Fall 2018 after spending 13 years in the Department of Biostatistics at University of Texas MD Anderson Cancer Center, Houston, Texas, where was a Professor and Institute Faculty Scholar and held adjunct appointments at Rice University, Texas A&M University and UT School of Public Health. His research interests are mainly in high-dimensional data modeling and Bayesian inference. This includes functional data analyses, Bayesian graphical models, Bayesian semi-/non-parametric models and Bayesian machine learning. These methods are motivated by large and complex datasets (a.k.a. Big Data) such as high-throughput genomics, epigenomics, transcriptomics and proteomics as well as high-resolution neuro- and cancer- imaging. His work has been published in top statistical/biostatistical/bioinformatics and biomedical/oncology journals. He has also co-authored a book on Bayesian analysis of gene expression data. He currently holds multiple PI-level grants from NIH and NSF to develop innovative and advanced biostatistical and bioinformatics methods for big datasets in oncology. He has also served as the Director of the Biostatistics and Bioinformatics Cores for the Specialized Programs of Research Excellence (SPOREs) in Multiple Myeloma and Lung Cancer and Biostatistics&Bioinformatics platform leader for the Myeloma and Melanoma Moonshot Programs at MD Anderson. He is a fellow of the American Statistical Association and an elected member of the International Statistical Institute. He currently serves as an Associate Editor for Journal of American Statistical Association, Biometrics and Sankhya.
I am a theoretical astrophysicist studying the origins and structure of galaxies in the universe. My research focuses on developing more realistic gasdynamics simulations, starting with the initial conditions that are well constrained by observations, and advancing them in time with high spatial resolution using adaptive mesh refinement. I use machine-learning techniques to compare simulation predictions with observational data. Such comparison leads to insights about the underlying physics that governs the formation of stars and galaxies. I have developed a Computational Astrophysics course that teaches practical application of modern techniques for big-data analysis and model fitting.
Prof. Huan’s research broadly revolves around uncertainty quantification, data-driven modeling, and numerical optimization. He focuses on methods to bridge together models and data: e.g., optimal experimental design, Bayesian statistical inference, uncertainty propagation in high-dimensional settings, and algorithms that are robust to model misspecification. He seeks to develop efficient numerical methods that integrate computationally-intensive models with big data, and combine uncertainty quantification with machine learning to enable robust and reliable prediction, design, and decision-making.
Dr. Feng’s research involves conducting and using naturalistic observational studies to better understand the interactions between motorists and other road users including bicyclists and pedestrians. The goal is to use an evidence-based, data-driven approach that improves bicycling and walking safety and ultimately makes them viable mobility options. A naturalistic study is a valuable and unique research method that provides continuous, high-time-resolution, rich, and objective data about how people drive/ride/walk for their everyday trips in the real world. It also faces challenges from the sheer volume of the data, and as with all observational studies, there are potential confounding factors compared to a randomized laboratory experiment. Data analytic methods can be developed to interpret the behavioral data, make meaningful inferences, and get actionable insights.
I study how law shapes innovation in the life sciences, with a substantial focus on big data and artificial intelligence in medicine. I write about the intellectual property incentives and protections for data and AI algorithms, the privacy issues with wide-scale health- and health-related data collection, the medical malpractice implications of AI in medicine, and how FDA should regulate the use of medical AI.
The future of transportation lies at the intersection of two emerging trends, namely, the sharing economy and connected and automated vehicle technology. Our research group investigates the impact of these two major trends on the future of mobility, quantifying the benefits and identifying the challenges of integrating these technologies into our current systems.
Our research on shared-use mobility systems focuses on peer-to-peer (P2P) ridesharing and multi-modal transportation. We provide: (i) operational tools and decision support systems for shared-use mobility in legacy as well as connected and automated transportation systems. This line of research focuses on system design as well as routing, scheduling, and pricing mechanisms to serve on-demand transportation requests; (ii) insights for regulators and policy makers on mobility benefits of multi-modal transportation; (ii) planning tools that would allow for informed regulations of sharing economy.
In another line of research we investigate challenges faced by the connected automated vehicle technology before mass adoption of this technology can occur. Our research mainly focuses on (i) transition of control authority between the human driver and the autonomous entity in semi-autonomous (level 3 SAE autonomy) vehicles; (ii) incorporating network-level information supplied by connected vehicle technology into traditional trajectory planning; (iii) improving vehicle localization by taking advantage of opportunities provided by connected vehicles; and (iv) cybersecurity challenges in connected and automated systems. We seek to quantify the mobility and safety implications of this disruptive technology, and provide insights that can allow for informed regulations.
My research interests are to improve safety associated with motor-vehicle transportation by addressing both active safety (increased crash avoidance) and passive safety (increased crash protection) issues through the development and application of a wide range of research methodologies. These methodologies are targeted at developing a better understanding and modeling of driver behavior, including physical and cognitive attributes, driver decision-making processes and human intention prediction. I am currently interested in applying data science to study the following topics:
*Driver state detection and prediction;
*Improve user intersection with automated vehicle technologies;
*Communication and interaction between vehicle and vulnerable road users
*Driving style classification
*Human factors issues associated with connected and automated vehicle technologies
The focus of Dr. Najarian’s research is on the design of signal/image processing and machine learning methods to create computer-assisted clinical decision support systems that improve patient care and reduce the costs of healthcare. Dr. Najarian’s lab also designs sensors to collect and analyze physiological signals and images. In particular, Dr. Najarian’s research focuses on creating decision support systems to manage traumatic brain injuries, traumatic pelvic/abdominal injuries and hypovolemia. Dr. Najarian’s research has been funded by agencies such as National Science Foundation and Department of Defense. He serves as the Editor-in-Chief of Biomedical Engineering and Computational Biology and the Associate Editor of two other journals in the field of biomedical informatics. He is also a member of the editorial board of many other journals and serves as the guest editor of special issues for several journals.